▶ Addresses a wide range of timely environment, economic and energy topics ▶ A forum to review, analyze and stimulate the development, testing and implementation of mitigation and adaptation strategies at regional, national and global scales ▶ Contributes to real-time policy analysis and development as national and international policies and agreements are discussed and promulgated ▶ 94% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Mitigation and Adaptation Strategies for Global Change

This paper presents a review of the turn of events and points of view of biogas in and its utilization for power, heat and in transport in the European Union (EU) and its Member States. Biogas creation has expanded in the EU, empowered by the sustainable power strategies, notwithstanding monetary, ecological and atmosphere benefits, to arrive at 18 billion m3 methane (654 PJ) in 2015, speaking to half of the worldwide biogas creation. The EU is the world chief in biogas power creation, with more than 10 GW introduced and various 17,400 biogas plants, in contrast with the worldwide biogas limit of 15 GW in 2015. In the EU, biogas conveyed 127 TJ of warmth and 61 TWh of power in 2015; about half of absolute biogas utilization in Europe was bound to warm age. Europe is the world's driving maker of biomethane for the utilization as a vehicle fuel or for infusion into the petroleum gas network, with 459 plants in 2015 creating 1.2 billion m3 and 340 plants taking care of into the gas network, with a limit of 1.5 million m3. Around 697 biomethane filling stations guaranteed the utilization 160 million m3 of biomethane as a transport fuel in 2015.

https://www.longdom.org/open-access/biogas-developments-and-perspectives-in-europe.pdf

Biogas Developments and Perspectives in Europe

Antibiotics, the most frequently prescribed drugs of modern medicine, are extensively used for both human and veterinary applications. Antibiotics from different wastewater sources (e.g., municipal, hospitals, animal production, and pharmaceutical industries) ultimately are discharged into wastewater treatment plants. Sorption and biodegradation are the two major removal pathways of antibiotics during biological wastewater treatment processes. This review provides the fundamental insights into sorption mechanisms and biodegradation pathways of different classes of antibiotics with diverse physical-chemical attributes. Important factors affecting sorption and biodegradation behavior of antibiotics are also highlighted. Furthermore, this review also sheds light on the critical role of extracellular polymeric substances on antibiotics adsorption and their removal in engineered biological wastewater treatment systems. Despite major advancements, engineered biological wastewater treatment systems are only moderately effective (48-77%) in the removal of antibiotics. In this review, we systematically summarize the behavior and removal of different antibiotics in various biological treatment systems with discussion on their removal efficiency, removal mechanisms, critical bioreactor operating conditions affecting antibiotics removal, and recent innovative advancements. Besides, relevant background information including antibiotics classification, physical-chemical properties, and their occurrence in the environment from different sources is also briefly covered. This review aims to advance our understanding of the fate of various classes of antibiotics in engineered biological wastewater treatment systems and outlines future research directions.

Insights into the Fate and Removal of Antibiotics in Engineered Biological Treatment Systems: A Critical Review

In this paper, we evaluated the ecotoxicological potential of the 100 pharmaceuticals expected to occur in highest quantities in the wastewater of a general hospital and a psychiatric center in Switzerland. We related the toxicity data to predicted concentrations in different wastewater streams to assess the overall risk potential for different scenarios, including conventional biological pretreatment in the hospital and urine source separation. The concentrations in wastewater were estimated with pharmaceutical usage information provided by the hospitals and literature data on human excretion into feces and urine. Environmental concentrations in the effluents of the exposure scenarios were predicted by estimating dilution in sewers and with literature data on elimination during wastewater treatment. Effect assessment was performed using quantitative structure-activity relationships because experimental ecotoxicity data were only available for less than 20% of the 100 pharmaceuticals with expected highest loads. As many pharmaceuticals are acids or bases, a correction for the speciation was implemented in the toxicity prediction model. The lists of Top-100 pharmaceuticals were distinctly different between the two hospital types with only 37 pharmaceuticals overlapping in both datasets. 31 Pharmaceuticals in the general hospital and 42 pharmaceuticals in the psychiatric center had a risk quotient above 0.01 and thus contributed to the mixture risk quotient. However, together they constituted only 14% (hospital) and 30% (psychiatry) of the load of pharmaceuticals. Hence, medical consumption data alone are insufficient predictors of environmental risk. The risk quotients were dominated by amiodarone, ritonavir, clotrimazole, and diclofenac. Only diclofenac is well researched in ecotoxicology, while amiodarone, ritonavir, and clotrimazole have no or very limited experimental fate or toxicity data available. The presented computational analysis thus helps setting priorities for further testing. Separate treatment of hospital wastewater would reduce the pharmaceutical load of wastewater treatment plants, and the risk from the newly identified priority pharmaceuticals. However, because high-risk pharmaceuticals are excreted mainly with feces, urine source separation is not a viable option for reducing the risk potential from hospital wastewater, while a sorption step could be beneficial.

Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater

/pdf/liolios-xerolibadiotes-enas-agnoemenos-makedonas-agonistes-xpyhzwqzhp.pdf

Λιόλιος Ξερολιβαδιώτης : ένας αγνοημένος Μακεδόνας αγωνιστής του '21 και λίγα για την ιστορία του Ξερολιβάδου/ Γιώργου Χ. Χιονίδη

Phosphorus is an essential nutrient for every organism on the Earth, yet it is also a potential environmental pollutant, which may cause eutrophication of water bodies. Wastewater treatment plants worldwide are struggling to eliminate phosphorus from effluents, at great cost, yet current research suggests that the world may deplete the more available phosphorus reserves by around 2300. This, in addition to environmental concerns, evokes the need for new phosphorus recovery techniques to be developed, to meet future generations needs for renewable phosphorus supply. Many studies have been, and are, carried out on phosphorus recovery from wastewater and its sludge, due to their high phosphorus content. Chemical precipitation is the main process for achieving a phosphorus-containing mineral suitable for reuse as a fertilizer, such as struvite. This paper reviews the current status and future trends of phosphorus production and consumption, and summarizes current recovery technologies, discussing their possible integration into wastewater treatment processes, according to a more sustainable water-energy-nutrient nexus.

/pdf/the-potential-phosphorus-crisis-resource-conservation-and-1kxg7u2ljo.pdf

The Potential Phosphorus Crisis: Resource Conservation and Possible Escape Technologies: A Review

Fossil fuel continued overuse and carbon emissions issues have prompted increased research efforts on sustainable and renewable energy sources as alternative to fossil fuels. Biofuels include produ...

Production technologies, current role, and future prospects of biofuels feedstocks: A state-of-the-art review

In many Countries, small communities are required to treat wastewater discharges to increasing standards of lesser environmental impacts, but must achieve that goal at locally sustainable costs. While biological membrane treatment (membrane bio-reactors (MBRs)) is quickly becoming the industry standard for centralized wastewater treatment plants, and would also be ideally suited also for small plants potentially subject to relatively large hydraulic load variations, its investment and operating costs are usually high for that class of applications. Consequently, small treatment plants are generally configured as anoxic or aerated biological tanks with little sedimentation, making them quite susceptible to hydraulic loads transient and sludge quality changes. As an alternative, Constructed Wetlands Systems (CWSs) are gradually and successfully being introduced in many Countries. CWSs are designed to utilise the natural functions of wetland vegetation, soils and their microbiological populations to treat wastewater. Pretreatment occurs by filtration and settling, followed by bacterial decomposition in a natural-looking lined marsh. A new technology, a new type of membrane-like aerobic reactor initially designed for the degradation of hydrocarbon-derived groundwater contaminants, was recently tested for treating domestic, with performance similar to that of MBRs. Examples from the above applications are illustrated and compared in this paper. The paper also discusses merits and drawbacks of the various illustrated technologies, in view of their sustainability potential, and according to the new development paradigms for urban water systems, that encourage the development of local water-cycle clusters with local reuse and recycle of the resource, and possible local recovery of energy and/or materials.

Sustainability of decentralized wastewater treatment technologies

Pharmaceutically active compounds are widely diffused in surface and ground water, entering the environment mainly through treated wastewater discharges, aside from specific sources such as pharmaceutical industry discharges, and threatening safety and use of water resources. Among various technologies that have been developed and applied to remove these compounds prior to discharge, membrane biological reactors (MBRs) and bioelectrochemical systems (BESs) have both shown encouraging results. MBRs have shown good removal efficiencies on a wide range of different compounds, both at the laboratory and full scales. In order to achieve the desired removal performances, the technology can be improved with additional features, such as activated carbon adsorption, carrier media for enhanced biofilm growth, and others. BESs, on the other hand, have shown that it is possible to produce energy while treating wastewater. This paper reviews and discusses current state-of-the–art technologies for pharmaceutically active compounds removal using MBRs and BESs, with a particular focus on innovative configurations; the future use of MBR-BES systems is also discussed.

Arianna Callegari

Papers

The Potential Phosphorus Crisis: Resource Conservation and Possible Escape Technologies: A Review

Production technologies, current role, and future prospects of biofuels feedstocks: A state-of-the-art review

Sustainability of decentralized wastewater treatment technologies

Biological combination processes for efficient removal of pharmaceutically active compounds from wastewater: A review and future perspectives

Agro-food industry wastewater treatment with microbial fuel cells: Energetic recovery issues